VF
AUPH icon

Virtu Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Virtu Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Buy
+14,742
New +$236K 0.01% 818
2025
Q4 		– Sell
-20,434
Closed -$226K – 1653
2025
Q3 		$226K Buy
+20,434
New +$223K 0.01% 864
2025
Q2 		– Sell
-14,727
Closed -$118K – 1442
2025
Q1 		$118K Buy
14,727
+4,074
+38% +$33K 0.01% 904
2024
Q4 		$96K Buy
+10,653
New +$86.9K 0.01% 1030
2024
Q3 		– Sell
-54,102
Closed -$309K – 1359
2024
Q2 		$309K Buy
54,102
+38,511
+247% +$203K 0.02% 587
2024
Q1 		$78K Buy
+15,591
New +$106K 0.01% 958
2023
Q3 		– Sell
-15,795
Closed -$153K – 1291
2023
Q2 		$153K Buy
+15,795
New +$164K 0.01% 901
2023
Q1 		– Sell
-30,873
Closed -$133K – 1521
2022
Q4 		$133K Buy
+30,873
New +$179K 0.02% 855
2022
Q3 		– Sell
-20,658
Closed -$208K – 1715
2022
Q2 		$208K Buy
20,658
+805
+4% +$9K 0.02% 749
2022
Q1 		$246K Buy
+19,853
New +$307K 0.02% 676
2021
Q3 		– Sell
-67,123
Closed -$870K – 1492
2021
Q2 		$870K Buy
+67,123
New +$855K 0.08% 247
2019
Q4 		$412K Sell
20,326
-2,462
-11% -$22.7K 0.04% 507
2019
Q3 		$122K Buy
+22,788
New +$138K 0.01% 1049
2019
Q1 		– Sell
-15,458
Closed -$105K – 1402
2018
Q4 		$105K Buy
+15,458
New +$89.1K 0.01% 1120
2018
Q3 		– Sell
-17,511
Closed -$99K – 1530
2018
Q2 		$99K Buy
+17,511
New +$97.7K 0.01% 1648
2017
Q4 		– Sell
-37,009
Closed -$232K – 2352
2017
Q3 		$232K Buy
+37,009
New +$233K 0.01% 1669

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's AUPH Position: Q2 2026 in Review

Virtu Financial opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 14,742 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #818 among its holdings. This is a return to the name: Virtu Financial previously reported a position in AUPH as recently as Q3 2025.

Virtu Financial first reported a position in AUPH in Q3 2017 and has held it in 16 quarters since. The position peaked at $870K in Q2 2021. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Virtu Financial held 14,742 shares of Aurinia Pharmaceuticals worth $250K as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Virtu Financial position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #818 holding.
  • Virtu Financial first reported a position in Aurinia Pharmaceuticals in Q3 2017 and has held it in 16 quarters since.
  • Virtu Financial's Aurinia Pharmaceuticals position peaked at $870K in Q2 2021.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.